Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$23.0M
-17.4% from 2023
Prescriptions
5,088
$4,528.96 per claim
Patients
630
714 prescribers
Total spending, 2024
$23.1M
$36,621.49 per patient
Medicare prescription drug plans paid $23.0M for Stribild in 2024, for 5,088 prescriptions and refills to 630 patients (down 17.4% from 2023). The average cost per claim was $4,528.96.
New York had the highest Medicare cost for Stribild in 2024: $3.3M for 705 claims, followed by Texas ($2.7M).
Frederick A Cruickshank, infectious disease in Huntersville, NC, had the highest Medicare cost for Stribild in 2024: 49 claims costing $222K.
Stribild is made by Gilead Sciences, Inc. (GILD), listed in the Medicare spending data as Gilead Sciences.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Frederick A Cruickshank Huntersville, NC | Infectious Disease | 49 | Under 11 | $222K |
| Joseph C Gathe Jr. Houston, TX | Infectious Disease | 52 | Under 11 | $208K |
| Judith A Lightfoot |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 995 | 7,708 | 950 | $32.1M |
| 2023 | 842 | 6,275 | 756 | $27.9M |
| 2024 | 714 | 5,088 | 630 | $23.0M |
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Infectious Disease |
| 44 |
| Under 11 |
| $174K |
| Michael R Byers Jackson, MS | Infectious Disease | 34 | Under 11 | $137K |
| Michael D Dorcik Biloxi, MS | Obstetrics & Gynecology | 25 | Under 11 | $136K |
| Damon C McMillan Tallahassee, FL | Family Practice | 33 | Under 11 | $133K |
| Kimberly A Workowski Atlanta, GA | Infectious Disease | 36 | Under 11 | $133K |
| Pardeep Kumari Pensacola, FL | Infectious Disease | 25 | Under 11 | $117K |
| Mark J Hupert Fort Worth, TX | Infectious Disease | 27 | Under 11 | $116K |
| Christopher L Miller Dothan, AL | Internal Medicine | 25 | Under 11 | $113K |
| Gina Winnette Statesboro, GA | Nurse Practitioner | 28 | Under 11 | $111K |
| Sara Zulfiqar Concord, NC | Infectious Disease | 23 | Under 11 | $110K |
| Manuel O Vasquez Bellaire, TX | Nurse Practitioner | 28 | Under 11 | $110K |
| Philip C Johnson III Houston, TX | Internal Medicine | 24 | Under 11 | $106K |
| Alexander A McMeeking New York, NY | Internal Medicine | 18 | Under 11 | $106K |
| Pablo M Tebas Philadelphia, PA | Infectious Disease | 23 | Under 11 | $104K |
| Patrick E Nolan Mobile, AL | Infectious Disease | 23 | Under 11 | $103K |
| Natalya Goldshteyn Brooklyn, NY | Infectious Disease | 24 | Under 11 | $101K |
| Donna E Sweet Wichita, KS | Internal Medicine | 24 | Under 11 | $99K |
| 1891742706 | Infectious Disease | 15 | Under 11 | $98K |
| Michelle V Lisgaris Cleveland, OH | Infectious Disease | 24 | Under 11 | $98K |
| Maxwell A Parrish Philadelphia, PA | Nurse Practitioner | 23 | Under 11 | $98K |
| Jeffrey E Galpin Tarzana, CA | Internal Medicine | 24 | Under 11 | $96K |
| James H Galbraith Dayton, OH | Infectious Disease | 24 | Under 11 | $93K |
| Edward Solis New York, NY | Internal Medicine | 21 | Under 11 | $93K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Gilead Sciences GILD | 5,111 | $23.1M |